Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Global health company The Cigna Group (NYSE: CI) today announced that Dr. Amy Flaster has been named Chief Medical Officer of T...
Wells Fargo analyst Stephen Baxter maintains Cigna Group (NYSE:CI) with a Equal-Weight and lowers the price target from $354...
Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting a...
TD Cowen analyst Charles Rhyee maintains Cigna Group (NYSE:CI) with a Buy and lowers the price target from $387 to $333.
Goldman Sachs analyst Scott Fidel maintains Cigna Group (NYSE:CI) with a Buy and lowers the price target from $370 to $330.
JP Morgan analyst Lisa Gill maintains Cigna Group (NYSE:CI) with a Overweight and lowers the price target from $428 to $375.
Barclays analyst Andrew Mok maintains Cigna Group (NYSE:CI) with a Overweight and lowers the price target from $383 to $300.
